• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服玉米淀粉和甘草甜素可改善IXa型糖原贮积病所致的严重肝损伤。

Oral Cornstarch and Glycyrrhizin Improve Severe Liver Injury Caused by Glycogen Storage Disease Type IXa.

作者信息

Miyaishi Masanori, Fukushima Kenji, Kuranobu Naomi, Murakami Jun, Namba Noriyuki

机构信息

Division of Pediatrics and Perinatology, Faculty of Medicine, Tottori University, Tottori, JPN.

出版信息

Cureus. 2025 Feb 2;17(2):e78396. doi: 10.7759/cureus.78396. eCollection 2025 Feb.

DOI:10.7759/cureus.78396
PMID:40046366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11880634/
Abstract

A previously healthy 18-month-old boy presented with hepatomegaly, accompanied by liver injury. Imaging and liver biopsy findings suggested a hepatic glycogen storage disease (GSD) but not GSD type I. Genetic testing revealed a partial deletion of the PHKA2 gene, confirming the diagnosis of GSD type IXa. Initial treatment included ursodeoxycholic acid and portioned meals. However, the boy's liver injury continued to worsen. Subsequently, nightly oral cornstarch after meals and oral glycyrrhizin were introduced. Following the addition of cornstarch and glycyrrhizin, the patient's liver injury significantly improved. Liver injury caused by GSD is likely due to excessive glycogen accumulation in the hepatocytes. However, the detailed mechanism is unclear, particularly the minimal inflammatory cell infiltration observed in this case. While GSD IX has a good prognosis and resolves spontaneously, some patients develop hepatic fibrosis and adenomas. Cornstarch supplementation is a mainstay treatment for GSD to prevent hypoglycemia. It may also contribute to improved liver function by moderating glycogen buildup. The glycyrrhizin has also shown potential in reducing mitochondrial damage via another mechanism in this case, but additional research is warranted.

摘要

一名此前健康的18个月大男孩出现肝肿大,并伴有肝损伤。影像学和肝活检结果提示为肝糖原贮积病(GSD),但非I型GSD。基因检测显示PHKA2基因部分缺失,确诊为IXa型GSD。初始治疗包括熊去氧胆酸和分餐。然而,该男孩的肝损伤持续恶化。随后,开始在餐后每晚口服玉米淀粉和口服甘草酸。添加玉米淀粉和甘草酸后,患者的肝损伤明显改善。GSD所致肝损伤可能是由于肝细胞中糖原过度蓄积。然而,具体机制尚不清楚,尤其是本病例中观察到的炎症细胞浸润极少。虽然IX型GSD预后良好且可自发缓解,但一些患者会发展为肝纤维化和腺瘤。补充玉米淀粉是GSD预防低血糖的主要治疗方法。它还可能通过减轻糖原堆积有助于改善肝功能。在本病例中,甘草酸还通过另一种机制显示出减少线粒体损伤的潜力,但仍需进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11880634/3b372c01dd5e/cureus-0017-00000078396-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11880634/82b87ed675d4/cureus-0017-00000078396-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11880634/e7b433f02cdf/cureus-0017-00000078396-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11880634/3b372c01dd5e/cureus-0017-00000078396-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11880634/82b87ed675d4/cureus-0017-00000078396-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11880634/e7b433f02cdf/cureus-0017-00000078396-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11880634/3b372c01dd5e/cureus-0017-00000078396-i03.jpg

相似文献

1
Oral Cornstarch and Glycyrrhizin Improve Severe Liver Injury Caused by Glycogen Storage Disease Type IXa.口服玉米淀粉和甘草甜素可改善IXa型糖原贮积病所致的严重肝损伤。
Cureus. 2025 Feb 2;17(2):e78396. doi: 10.7759/cureus.78396. eCollection 2025 Feb.
2
Mutation in PHKA2 leading to childhood glycogen storage disease type IXa: A case report and literature review.PHKA2基因突变导致儿童IXa型糖原贮积病:一例报告及文献复习
Medicine (Baltimore). 2019 Nov;98(46):e17775. doi: 10.1097/MD.0000000000017775.
3
A case study of a liver transplant-treated patient with glycogen storage disease type Ia presenting with multiple inflammatory hepatic adenomas: an analysis of clinicopathologic and genetic data.糖原贮积病 Ia 型肝移植治疗患者伴多发性炎症性肝腺瘤病例研究:临床病理和遗传学数据分析。
BMC Med Genomics. 2024 May 6;17(1):124. doi: 10.1186/s12920-024-01888-6.
4
A novel PHKA2 mutation in a Chinese child with glycogen storage disease type IXa: a case report and literature review.一个中国糖原贮积病 IXa 型患儿的新型 PHKA2 突变:病例报告及文献复习。
BMC Med Genet. 2019 Mar 29;20(1):56. doi: 10.1186/s12881-019-0789-8.
5
Molecular diagnosis of glycogen storage disease type IX using a glycogen storage disease gene panel.使用糖原贮积病基因检测板对IX型糖原贮积病进行分子诊断。
Eur J Med Genet. 2020 Jun;63(6):103921. doi: 10.1016/j.ejmg.2020.103921. Epub 2020 Mar 31.
6
The natural history of glycogen storage disease types VI and IX: Long-term outcome from the largest metabolic center in Canada.VI型和IX型糖原贮积病的自然病史:来自加拿大最大代谢中心的长期结果。
Mol Genet Metab. 2014 Nov;113(3):171-6. doi: 10.1016/j.ymgme.2014.09.005. Epub 2014 Sep 21.
7
Clinical and genetic characteristics of 17 Chinese patients with glycogen storage disease type IXa.17例中国IXa型糖原贮积病患者的临床和遗传特征
Gene. 2017 Sep 5;627:149-156. doi: 10.1016/j.gene.2017.06.026. Epub 2017 Jun 13.
8
Modifiable factors affecting renal preservation in type I glycogen storage disease after liver transplantation: a single-center propensity-match cohort study.影响肝移植后Ⅰ型糖原贮积病患者肾脏保存的可调节因素:单中心倾向评分匹配队列研究。
Orphanet J Rare Dis. 2021 Oct 11;16(1):423. doi: 10.1186/s13023-021-02026-6.
9
Impact of hematopoietic stem cell transplantation in glycogen storage disease type Ib: A single-subject research design using C-glucose breath test.造血干细胞移植对Ⅰb型糖原贮积病的影响:一项采用¹³C-葡萄糖呼气试验的单病例研究设计
Mol Genet Metab Rep. 2023 Jan 3;34:100955. doi: 10.1016/j.ymgmr.2023.100955. eCollection 2023 Mar.
10
A rare variant (p.G991A) identified in a patient with ketotic hypoglycemia.在一名酮症性低血糖患者中鉴定出一种罕见变异(p.G991A)。
JIMD Rep. 2019 May 28;48(1):15-18. doi: 10.1002/jmd2.12041. eCollection 2019 Jul.

本文引用的文献

1
Interleukin 25 and its biological features and function in intestinal diseases.白细胞介素25及其在肠道疾病中的生物学特性与功能
Cent Eur J Immunol. 2022;47(4):362-372. doi: 10.5114/ceji.2022.124416. Epub 2023 Jan 31.
2
Post-treatment with glycyrrhizin can attenuate hepatic mitochondrial damage induced by acetaminophen in mice.甘草酸治疗可减轻对乙酰氨基酚诱导的小鼠肝线粒体损伤。
Exp Biol Med (Maywood). 2021 May;246(10):1219-1227. doi: 10.1177/1535370220977823. Epub 2020 Dec 20.
3
Benign or not benign? Deep phenotyping of liver Glycogen Storage Disease IX.
良性还是非良性?肝糖原贮积症 IX 的深度表型分析。
Mol Genet Metab. 2020 Nov;131(3):299-305. doi: 10.1016/j.ymgme.2020.10.004. Epub 2020 Oct 10.
4
Glycyrrhizin improves inflammation and apoptosis via suppressing HMGB1 and PI3K/mTOR pathway in lipopolysaccharide-induced acute liver injury.甘草酸通过抑制脂多糖诱导的急性肝损伤中的 HMGB1 和 PI3K/mTOR 通路改善炎症和细胞凋亡。
Eur Rev Med Pharmacol Sci. 2020 Jun;24(12):7122-7130. doi: 10.26355/eurrev_202006_21706.
5
Liver histology in children with glycogen storage disorders type VI and IX.儿童糖原贮积症 VI 型和 IX 型的肝脏组织学检查。
Dig Liver Dis. 2021 Jan;53(1):86-93. doi: 10.1016/j.dld.2020.04.017. Epub 2020 Jun 4.
6
Dietary Management of the Glycogen Storage Diseases: Evolution of Treatment and Ongoing Controversies.糖原贮积病的饮食管理:治疗方法的演变及持续存在的争议。
Adv Nutr. 2020 Mar 1;11(2):439-446. doi: 10.1093/advances/nmz092.
7
Diagnosis and management of glycogen storage diseases type VI and IX: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).糖原贮积病 VI 型和 IX 型的诊断与管理:美国医学遗传学与基因组学学会(ACMG)临床实践资源
Genet Med. 2019 Apr;21(4):772-789. doi: 10.1038/s41436-018-0364-2. Epub 2019 Jan 19.
8
Glycyrrhizin alleviates Con A-induced hepatitis by differentially regulating the production of IL-17 and IL-25.甘草酸通过差异调节白介素-17 和白介素-25 的产生来缓解 Con A 诱导的肝炎。
Biomed Pharmacother. 2019 Feb;110:692-699. doi: 10.1016/j.biopha.2018.12.025. Epub 2018 Dec 12.
9
Hepatic mitochondrial dysfunction is a feature of Glycogen Storage Disease Type Ia (GSDIa).肝线粒体功能障碍是糖原贮积症 Ia 型 (GSDIa) 的特征。
Sci Rep. 2017 Mar 20;7:44408. doi: 10.1038/srep44408.
10
Glycyrrhizin Protects against Acetaminophen-Induced Acute Liver Injury via Alleviating Tumor Necrosis Factor α-Mediated Apoptosis.甘草酸通过减轻肿瘤坏死因子α介导的细胞凋亡来预防对乙酰氨基酚诱导的急性肝损伤。
Drug Metab Dispos. 2016 May;44(5):720-31. doi: 10.1124/dmd.116.069419. Epub 2016 Mar 10.